Skip to main content
SpringerLink
Log in

Ivabradine: a guide to its use in chronic stable angina pectoris

  • Drug and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 2006 Jun; 27(11): 1341–81

    Article  PubMed  Google Scholar 

  2. Thadani U. The pursuits of optimum outcomes in stable angina. Am J Cardiovasc Drugs 2003; 3Suppl. 1: 11–20

    Article  Google Scholar 

  3. Berdeaux A. Preclinical results with If current inhibition by ivabradine. Drugs 2007; 67Suppl. 2: 25–33

    Article  PubMed  Google Scholar 

  4. European Medicines Agency. Corlentor film-coated tablets: summary of product characteristics [online]. Available from URL: http://www.ema.europa.eu [Accessed 2010 Mar 25]

  5. European Medicines Agency. Procoralan film-coated tablets: summary of product characteristics [online]. Available from URL: http://www.ema.europa.eu [Accessed 2010 Mar 25]

  6. Tardif J-C. Heart rate as a treatable cardiovascular risk factor. Br Med Bull 2009; 90(1): 71–84

    Article  PubMed  Google Scholar 

  7. Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs 2007; 67Suppl. 3: 3–13

    Article  PubMed  Google Scholar 

  8. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008 Sep 6; 372(9641): 817–21

    Article  PubMed  Google Scholar 

  9. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003 Feb 18; 107(6): 817–23

    Article  PubMed  Google Scholar 

  10. Tardif J-C, Ford I, Tendera M, et al. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005 Dec; 26(23): 2529–36

    Article  PubMed  CAS  Google Scholar 

  11. Ruzyllo W, Tendera M, Ford I, et al. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs 2007; 67(3): 393–405

    Article  PubMed  CAS  Google Scholar 

  12. López-Bescós L, Filipova S, Martos R. Long-term safety and efficacy of ivabradine in patients with chronic stable angina. Cardiology 2007; 108(4): 387–96

    Article  PubMed  Google Scholar 

  13. Tardif JC, Ponikowski P, Kahan T. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 2009 Mar; 30(5): 540–8

    Article  PubMed  CAS  Google Scholar 

  14. Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008 Sep 6; 372(9641): 807–16

    Article  PubMed  CAS  Google Scholar 

  15. Tendera M, Borer JS, Tardif J-C. Efficacy of If inhibition with ivabradine in different subpopulations with stable angina pectoris. Cardiology 2009; 114(2): 116–25

    Article  PubMed  CAS  Google Scholar 

  16. Fox K, Ford I, Steg PG, et al. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 2009 Oct; 30(19): 2337–45

    Article  PubMed  CAS  Google Scholar 

  17. Savelieva I, Camm AJ. If inhibition with ivabradine: electro-physiological effects and safety. Drug Saf 2008; 31(2): 95–107

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivabradine: a guide to its use in chronic stable angina pectoris. Drugs Ther. Perspect 26, 6–9 (2010). https://doi.org/10.2165/11203390-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11203390-000000000-00000

Search

Navigation